Prescribing Antiplatelet Medicine and Subsequent Events After Intracerebral Hemorrhage | Zendy

Robert Flynn | Zendy; Thomas M. MacDonald | Zendy; Gordon Murray | Zendy; Ronald S. MacWalter | Zendy; Alex S. F. Doney | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prescribing Antiplatelet Medicine and Subsequent Events After Intracerebral Hemorrhage

Author(s) -

Robert Flynn,

Thomas M. MacDonald,

Gordon Murray,

Ronald S. MacWalter,

Alex S. F. Doney

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.589143

Subject(s) - medicine , intracerebral hemorrhage , hazard ratio , confidence interval , stroke (engine) , antiplatelet drug , myocardial infarction , proportional hazards model , cardiology , clopidogrel , subarachnoid hemorrhage , mechanical engineering , engineering

Antiplatelet medicines are commonly perceived as contraindicated after intracerebral hemorrhage (ICH). Many ICH patients have or will have indications for antiplatelet therapy. This observational study describes the level of antiplatelet prescribing and rate of subsequent events after ICH in Tayside, Scotland.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research